ArticleNanoscale advances2022
Ag@Au bimetallic nanoparticles: an easy and highly reproducible synthetic approach for photocatalysis.
Article in Nanoscale advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Cationic carbon dot-silver nanohybrids with enhanced stability and redox control.Discover nano · 2026Article
- Functionalized Core/Shell Gold-Palladium Bimetallic Nanoparticles in Transferrin-Targeted Dual-Drug Delivery in a Cervical Cancer Cell Model.Pharmaceuticals (Basel, Switzerland) · 2025Article
- Salmon-IgM Functionalized-PLGA Nanosystem for Florfenicol Delivery as an Antimicrobial Strategy againstNanomaterials (Basel, Switzerland) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An Ag@Au bimetallic nanoparticle (BNP) formulation was developed in this work. The proposed formulation was developed using photochemical and chemical methods and non-toxic reagents, showing high reproducibility and homogeneity. The synthesized BNPs have an average size of 7 nm, a core-shell-like structure (silver core and gold shell), high colloidal and long-term stability, and superior catalytic activity under darkness and white light irradiation conditions when evaluating the reduction of 4-nitrophenol to 4-aminophenolate, with respect to the monometallic Ag and Au counterparts. Furthermore, BNP concentrations as low as 2 nM were required to reach 100% conversions in less than 30 minutes. Therefore, considering future applications, the high surface-to-volume ratio of the prepared BNPs coupled with their well-defined optical properties makes them a great candidate for developing heterogeneous catalyzer materials to be applicable under sunlight as an environmentally friendly catalytic system.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.